Skip to main content
. 2008 Sep 3;15(10):1572–1579. doi: 10.1128/CVI.00156-08

TABLE 3.

Efficacy of live KBNP-C4152R2L vaccine against a different genotype (III) virus, KJW

Group Vaccine titer (EID50) Test virus HI titer at 21 DPI (log2) Survival ratea
Control 0 La Sota 0 0/13 (0)
KBNP-C4152R2L 0
KBNP-C4152R2L 105 La Sota 4.6 ± 0.9 11/11 (100)
KBNP-C4152R2L 5.3 ± 0.5
106 La Sota 5.3 ± 1.1 12/12 (100)
KBNP-C4152R2L 5.7 ± 0.6
107 La Sota 4.7 ± 1.3 13/13 (100)
KBNP-C4152R2L 5.2 ± 0.7
108 La Sota 5.1 ± 1.2 13/13 (100)
KBNP-C4152R2L 5.3 ± 1.0
Avinew 1 dose La Sota 7.3 ± 1.2 12/12 (100)
KBNP-C4152R2L 6.2 ± 1.3
a

Survival rate after challenge with KJW (2 × 105 TCID50/chicken on DPI 22 via the intranasal route), shown as number surviving/total number challenged (percent).